Reliable detection of neurological biomarkers in blood and cerebrospinal fluid (CSF) remains a key challenge in neurodegenerative disease research. Many of these markers are present at very low concentrations, and biological samples can contain components that interfere with accurate measurement.

Biomedical Scientist recently published ‘A preventative approach for Alzheimer’s’, which explores the first study evaluating the impact of obesity on Alzheimer’s blood biomarkers.

The interleukin-2 receptor (IL-2R), also known as CD25, is a transmembrane protein, which is up-regulated on activated T-cells, and shed into serum as soluble IL-2R...